Journals in Medicine
Journals in Medicine
The Medicine portfolio strives to advance medicine by delivering superior evidence-based education, reference information and decision support tools to clinicians, trainees, and students. Specialties covered include Anesthesiology, Internal Medicine, Surgery, Radiology & Imaging, Pathology, Orthopedics, Ophthalmology, Infectious Disease, Allergy & Immunology, Pediatrics, Obstetrics & Gynecology, Hematology & Oncology, Plastic Surgery, and many more. The Medicine portfolio includes world-renowned titles such as Gray's Anatomy and Netter Atlas of Human Anatomy, Braunwald's Heart Disease, Goldman-Cecil Medicine, Osborn's Brain, Dermatology (Bolognia), Diagnostic Ultrasound (Rumack), The Harriet Lane Handbook, Fanaroff and Martin's Neonatal-Perinatal Medicine, Ferri's Clinical Advisor, Conn's Current Therapy, and more.
Health Policy and Technology
Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments.HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.Topics covered by HPT will include:- Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems - Cross-national comparisons on health policy using evidence-based approaches - National studies on health policy to determine the outcomes of technology-driven initiatives - Cross-border eHealth including health tourism - The digital divide in mobility, access and affordability of healthcare - Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies - Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies - Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making - Stakeholder engagement with health technologies (clinical and patient/citizen buy-in) - Regulation and health economicsAbout the FPM The aim of the Fellowship of Postgraduate Medicine (FPM) is to promote international calibre excellence in postgraduate medical education through its publications, clinical and scientific meetings, and other activities. The FPM is a British medical charity that was founded at the end of World War I, when it pioneered development of post-graduate educational programs in all branches of medicine.Its foundation was the result of a merger between the Fellowship of Medicine and the Postgraduate Medical Association, with Sir William Osler the first president of the new organization. The FPM is supported by Fellows with expertise in the practice of medicine, medical education and publishing, and research in medicine and related disciplines.- ISSN: 2211-8837
Maturitas
Official Journal of the European Menopause and Andropause Society (EMAS). Affiliated with the Australasian Menopause Society (AMS).Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond publishing original research, reviews, consensus statements and guidelines, and mini-reviews. The journal provides a forum for all aspects of postreproductive health in both genders ranging from basic science to health and social care.Topic areas include:AgingAlterna... and Complementary MedicinesArthritis and Bone HealthCancerCardiova... HealthCognitive and Physical FunctioningEpidemiol... Health and Social CareGynecology/Endoc... Ovarian AgingMental HealthNutrition/ Obesity Diabetes/ Metabolic SyndromePharmacology... of LifeSexualityMaturit... provides a lively and high visibility platform to encourage new insights and exchange of important new developments between researchers, clinicians and care providers in the field of midlife health to promote a personalized approach to healthy aging.- ISSN: 0378-5122
The Journal of Allergy and Clinical Immunology: In Practice
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), and a companion title to the field-leading The Journal of Allergy and Clinical Immunology . It brings timely clinical papers, instructive case reports, and the latest management recommendations to clinical allergists and other physicians concerned with clinical manifestations of allergic and immunologic diseases in their practice.Vision The vision of JACI: In Practice is to be an indispensable resource for clinicians who manage patients with asthma, allergic, immunologic, and related conditions in order to optimize the care and health of these patients.Mission The mission of JACI: In Practice is to provide novel, valid, generalizable, and impactful information to support evidence-based clinical decisions in the diagnosis and management of asthma, allergic, immunologic, and related conditions.AAAAI Journals Diversity Statement Equity and inclusion in publishing are critically important for scientific innovation and excellence. The AAAAI Journals value inclusion and diversity across research, through its various lenses, be it authors, reviewers, or editors. This is in line with the AAAAI Diversity Equity and Inclusion Statement as well as Elsevier's support of the joint commitment for action on inclusion and diversity in publishing. We are committed to multilevel initiatives to promote diversity, equity, and inclusion in the articles we publish and in the people who write, review, and edit them.Scope JACI: In Practice publishes clinically impactful articles on the spectrum of conditions treated by allergist-immunologi... in their practice: food allergy, respiratory disorders (including asthma, allergic and nonallergic rhinitis/rhinoconjun... nasal polyps, chronic sinusitis, cough, allergic bronchopulmonary aspergillosis [ABPA], and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (including atopic dermatitis, contact dermatitis, urticaria, angioedema, and hereditary angioedema [HAE]), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The Journal emphasizes cutting edge practical clinical information for practitioners that they can use in everyday practice or will help them acquire new knowledge or skills they can directly apply to patient care. Mechanistic or translational studies without immediate or near future clinical relevance and animal studies are not within the scope of the Journal.Content All JACI: In Practice content is peer-reviewed. The Journal welcomes original research articles that fit into the above scope. For each Original Article, a highlight box indicates what is already known about this subject, what this study adds, and how the new information impacts current management guidelines. Shorter original research and instructive case reports are presented as Clinical Communications. "Images in Allergy" articles consist of clinical pictures (eg, X-rays, CT scans, biopsies, allergens, endoscopic visualizations of the airway, eruptions, etc.) and impart important clinical information. In addition, JACI: In Practice features various types of review articles that will primarily be invited by the editors. Many of these offer CME, and the invited Difficult Cases feature offers MOC credit. The original and review articles are supplemented by Editorials, AAAAI Practice Papers, Practice Options From Beyond Our Pages, Ask the Expert, and Practice Pearls features.Contact Us Editorial Office: [email protected]... Tel 720-446-2822 Editorial Manager submission site: https://www.editoria... AAAAI: [email protected]; Tel 414-272-6071- ISSN: 2213-2198
Cell Calcium
Cell Calcium covers the field of calcium metabolism and signalling in living systems, from aspects including inorganic chemistry, physiology, molecular biology and pathology. Topic themes include:Roles of calcium in regulating cellular events such as apoptosis, necrosis and organelle remodellingInfluence of calcium regulation in affecting health and disease outcomes- ISSN: 0143-4160
Free Radical Biology & Medicine
The journal Free Radical Biology and Medicine is the premier forum for publishing ground-breaking research in the redox biology of both health and disease. We focus on signal transduction and redox signaling; oxidative stress; reductive stress; redox stress; nitrosative stress; aging and age-related diseases; redox biology in skeletal and cardiac muscle, exercise science, and sports medicine; metabolic regulation and metabolic diseases; mitochondrial function and signaling; homeostatic mechanisms and adaptive responses; redox chemistry and mechanisms; materials and nanomaterials; non-thermal plasmas; microorganisms, fungi, plants, insects, animals, and humans; and antioxidant enzymes, pathways, and networks.The journal welcomes both full-length and short Research Communications, Hypothesis Papers, Reviews, Mini Reviews, Graphical Reviews, and Critical Methods Papers. Free Radical Biology and Medicine is the official journal of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe, and affiliate journal of the International Society for Free Radical Research (SFRRI)- ISSN: 0891-5849
Biochimica et Biophysica Acta: Molecular Basis of Disease
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiov... diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunologica... diseasesInflammatory diseasesMetabolic diseasesMitochondria... diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computation... (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descripti... or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparati... Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.- ISSN: 0925-4439
Genetics in Medicine
Genetics in Medicine (GIM) is an official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal is an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.In addition:GIM does not publish case reportsManuscripts reporting population level research carried out in predominantly or exclusively White populations will generally not be accepted without strong justification for lack of diversity in the population studied.The significance of articles reporting data and/or observations from a limited geographic region is evaluated in the context of whether they are generalizable across relevant populations or whether they might fill a knowledge gap in populations that are underrepresented in genetics research or that experience health disparities.Although cancer genetics is a focus, GIM discourages cancer genetics manuscripts with data limited to somatic and/or tumor genetics. Manuscripts with novel findings on non-germline genetics (for example, somatic [tumor] variation, CHIP [clonal hematopoiesis of indeterminate potential], somatic and constitutional mosaicism) that inform our understanding of germline risk may also be considered. Manuscripts reporting on circulating tumor DNA (ctDNA) or "liquid biopsy" are also generally not within the scope of GIM.Manuscripts should not contain previously published material without appropriate permission.GWAS studies are generally low priority for GIM.- ISSN: 1098-3600
Advances in Biological Regulation
Advances in Biological Regulation (formerly Advances in Enzyme Regulation) reports cutting edge scientific progress on regulation at the molecular level, covering:The molecular biology of control of gene expression by hormones, drugs and growth factors in cancer cells and in clinical situations of metabolic diseases, inborn errors of metabolism and neoplasia.Stem cell biology and regenerative medicine issuesRegulatory networks, mainly in cellular signalling, differentiation, cell cycle & growth control, structure-function relationships, cell fate and lineage commitment or assembly mechanisms in cellsViruses, or supramolecular constructs, and signaling mechanisms mediating transcriptionGenomic... proteomic, bioinformatics and systems biology approaches to identify and characterize steps of biological control in cells.Complex cellular, pathogenic, clinical, or animal model systems studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches- ISSN: 2212-4926
Cellular Signalling
Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.- ISSN: 0898-6568
Journal of Allergy and Clinical Immunology
Official Journal of the American Academy of Allergy, Asthma and ImmunologyThe Journal of Allergy and Clinical Immunology publishes high-impact, cutting-edge basic, clinical and translational research papers in Allergy, Asthma and Immunology. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. With an impact factor of 11.2, the journal ranks 3rd out of 39 journals in the Allergy category and 11th of 183 journals in the Immunology category in the 2024 Journal Citation Reports®, published by Clarivate.Authors are also welcome to submit to the journal's companion titles, The Journal of Allergy and Clinical Immunology: In Practice and the Gold Open Access title, The Journal of Allergy and Clinical Immunology: Global. For more information on the articles reviewed by JACI: In Practice and JACI: Global, please visit their respective websites which are linked here: www.jaci-inpractice.... www.jaci-global.org- ISSN: 0091-6749
